Neglia D, Parodi O, Gallopin M, Sambuceti G, Giorgetti A, Pratali L, Salvadori P, Michelassi C, Lunardi M, Pelosi G
Institute of Clinical Physiology, National Council of Research, Pisa, Italy.
Circulation. 1995 Aug 15;92(4):796-804. doi: 10.1161/01.cir.92.4.796.
Myocardial blood flow (MBF) impairment has been documented in advanced dilated cardiomyopathy (DCM) in which hemodynamic factors, secondary to severe ventricular dysfunction, may limit myocardial perfusion. To assess whether MBF impairment in DCM may also be present independent of hemodynamic factors, the present study was designed to quantify myocardial perfusion in patients with mild disease without overt heart failure.
Absolute regional MBF (milliliters per minute per gram) was measured by positron emission tomography and 13N-ammonia in resting conditions, during pacing-induced tachycardia, and after dipyridamole infusion (0.56 mg/kg over 4 minutes) in 22 DCM patients and in 13 healthy subjects. Patients were in New York Heart Association functional class I-II and showed depressed left ventricular (LV) ejection fraction by radionuclide angiography (35 +/- 8%; range, 21% to 48%), normal coronary angiography, and normal or moderately increased LV end-diastolic pressure (9.2 +/- 5.5 mm Hg; range, 2 to 20 mm Hg). There were no differences in arterial blood pressure, heart rate, and rate-pressure product between patients and control subjects in the three study conditions. Compared with control subjects, DCM patients had lower mean MBF at rest (0.80 +/- 0.25 versus 1.08 +/- 0.20 mL.min-1.g-1, P < .01), during atrial pacing tachycardia (1.21 +/- 0.59 versus 2.03 +/- 0.64 mL.min-1.g-1, P < .01), and after dipyridamole infusion (1.91 +/- 0.76 versus 3.78 +/- 0.86 mL.min-1.g-1, P < .01). LV MBF values were related to baseline LV end-diastolic pressure at rest (r = -.57, P < .01) and during pacing (r = -.67, P < .01) but not after dipyridamole infusion (r = .19, P = .40). Five patients had LV end-diastolic pressure > 12 mm Hg; in 4, myocardial perfusion was severely depressed both at baseline and in response to stress.
In patients with DCM without overt heart failure, myocardial perfusion is impaired both at rest and in response to vasodilating stimuli. The abnormalities in vasodilating capability can be present despite normal hemodynamics; progression of the disease is associated with more depressed myocardial perfusion.
在晚期扩张型心肌病(DCM)中已证实存在心肌血流(MBF)受损,其中继发于严重心室功能障碍的血流动力学因素可能会限制心肌灌注。为了评估DCM中的MBF受损是否也可能独立于血流动力学因素而存在,本研究旨在对无明显心力衰竭的轻症患者的心肌灌注进行量化。
通过正电子发射断层扫描和13N-氨在静息状态、起搏诱发心动过速期间以及在22例DCM患者和13例健康受试者中静脉注射双嘧达莫(4分钟内0.56mg/kg)后测量绝对局部MBF(每分钟每克毫升数)。患者处于纽约心脏协会功能分级I-II级,通过放射性核素血管造影显示左心室(LV)射血分数降低(35±8%;范围21%至48%),冠状动脉造影正常,LV舒张末期压力正常或中度升高(9.2±5.5mmHg;范围2至20mmHg)。在三种研究状态下,患者与对照受试者之间的动脉血压、心率和心率-血压乘积无差异。与对照受试者相比,DCM患者在静息时平均MBF较低(0.80±0.25对1.08±0.20mL·min-1·g-1,P<.01),在心房起搏心动过速期间(1.21±0.59对2.03±0.64mL·min-1·g-1,P<.01),以及在双嘧达莫注射后(1.91±0.76对3.78±0.86mL·min-1·g-1,P<.01)。LV的MBF值与静息时(r = -.57,P<.01)和起搏期间(r = -.67,P<.01)的基线LV舒张末期压力相关,但与双嘧达莫注射后无关(r = .19,P = .40)。5例患者LV舒张末期压力>12mmHg;其中4例患者的心肌灌注在基线和应激反应时均严重降低。
在无明显心力衰竭的DCM患者中,静息时和对血管扩张刺激的反应中均存在心肌灌注受损。尽管血流动力学正常,但血管扩张能力仍可能存在异常;疾病进展与更严重的心肌灌注降低相关。